Each tablet contains 5 mg of aripiprazole
... Weight gain: weight gain is commonly seen in schizophrenic and bipolar mania patients due to comorbidities, use of antipsychotics known to cause weight gain, poorly managed life-style, and might lead to severe complications. Weight gain has been reported post-marketing among patients prescribed ABIL ...
... Weight gain: weight gain is commonly seen in schizophrenic and bipolar mania patients due to comorbidities, use of antipsychotics known to cause weight gain, poorly managed life-style, and might lead to severe complications. Weight gain has been reported post-marketing among patients prescribed ABIL ...
Nicotine and Schizophrenia
... It has been proposed that smokers with schizophrenia are more efficient smokers, who absorb more nicotine per cigarette than do smokers without this disorder. ...
... It has been proposed that smokers with schizophrenia are more efficient smokers, who absorb more nicotine per cigarette than do smokers without this disorder. ...
Dopaminergic Pathways and their
... adrenaline, there is as yet little evidence of important peripheral dopaminergic pathways. Dopamine infusions are used in the treatment of shock (Goldberg, 1972). Although dopamine is not a potent alpha agonist, as compared with noradrenaline, at high doses dopamine causes a rise in blood pressure, ...
... adrenaline, there is as yet little evidence of important peripheral dopaminergic pathways. Dopamine infusions are used in the treatment of shock (Goldberg, 1972). Although dopamine is not a potent alpha agonist, as compared with noradrenaline, at high doses dopamine causes a rise in blood pressure, ...
No Slide Title
... Dose: 750 - 2500 mg/day (50-125 g /mL) Pros: Efficacy in mania established Better than Li in mixed states and rapid cyclers Well-tolerated Cons : ? Efficacy in prophylaxis Weight gain, nausea, hair loss, tremor, platelets, liver & pancreas toxicity, ?polycystic ovary disease ...
... Dose: 750 - 2500 mg/day (50-125 g /mL) Pros: Efficacy in mania established Better than Li in mixed states and rapid cyclers Well-tolerated Cons : ? Efficacy in prophylaxis Weight gain, nausea, hair loss, tremor, platelets, liver & pancreas toxicity, ?polycystic ovary disease ...
Ziprasidon Pfizer capsule hard ENG SmPC
... An approximately 3-fold increased risk of cerebrovascular adverse events has been seen in randomised placebo-controlled clinical trials in the dementia population with some atypical antipsychotics. The mechanism for this increased risk is not known. An increased risk cannot be excluded for other ant ...
... An approximately 3-fold increased risk of cerebrovascular adverse events has been seen in randomised placebo-controlled clinical trials in the dementia population with some atypical antipsychotics. The mechanism for this increased risk is not known. An increased risk cannot be excluded for other ant ...
Antidepressant Drugs - Vendor Drug Program
... disorder (OCD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and posttraumatic stress disorder (PTSD). Additionally, bupropion is FDA-approved for seasonal affective disorder (AD) and smoking cessation (SC), fluoxetin ...
... disorder (OCD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and posttraumatic stress disorder (PTSD). Additionally, bupropion is FDA-approved for seasonal affective disorder (AD) and smoking cessation (SC), fluoxetin ...
Adverse Effects of Antiepileptic Drugs
... Variations in labeling adverse effects and the use of different descriptive terms, as noted previously, create problems in comparing adverse effects of AEDs. Another problem with current reports of adverse effects is that objective quantifiable measures of most complaints are not used frequently in ...
... Variations in labeling adverse effects and the use of different descriptive terms, as noted previously, create problems in comparing adverse effects of AEDs. Another problem with current reports of adverse effects is that objective quantifiable measures of most complaints are not used frequently in ...
A Review of Interventions for Treatment
... still meets the criteria for PTSD is considered treatment-resistant. Additionally, some patients who experience partial response to treatment can still meet the criteria for a diagnosis of PTSD and are therefore also considered treatment-resistant. The definition of treatment resistance may vary acr ...
... still meets the criteria for PTSD is considered treatment-resistant. Additionally, some patients who experience partial response to treatment can still meet the criteria for a diagnosis of PTSD and are therefore also considered treatment-resistant. The definition of treatment resistance may vary acr ...
Current And Emerging Therapeutics Of Autistic Disorder
... and irritability. In contrast, transdermal clonidine (5 g per kg daily) was reported to be effective in a double-blind, placebo-controlled crossover study (4 weeks in each treatment phase) involving nine males (ages 5 to 33 years) with autistic disorder (21). Significant improvement was seen on the ...
... and irritability. In contrast, transdermal clonidine (5 g per kg daily) was reported to be effective in a double-blind, placebo-controlled crossover study (4 weeks in each treatment phase) involving nine males (ages 5 to 33 years) with autistic disorder (21). Significant improvement was seen on the ...
Potentially Harmful Drugs in the Elderly: Beers List
... Pharmacotherapy of Dementia Behaviors, for alternatives. Quetiapine or clozapine may be the best choice for Parkinson’s disease patients if antipsychotic needed. All antipsychotics associated with increased stroke and mortality risk when used to treat behavioral problems in elderly with dementia.2 S ...
... Pharmacotherapy of Dementia Behaviors, for alternatives. Quetiapine or clozapine may be the best choice for Parkinson’s disease patients if antipsychotic needed. All antipsychotics associated with increased stroke and mortality risk when used to treat behavioral problems in elderly with dementia.2 S ...
SNRIs: an approach - Psychopharmacology Institute
... • Relatively easy to combine with other antidepressants, “California Rocket Fuel” • Complementary MOA • STAR*D: • Mirtazapine+ Venlafaxine outperformed tranylcypromine (1) • Not statistically significant ...
... • Relatively easy to combine with other antidepressants, “California Rocket Fuel” • Complementary MOA • STAR*D: • Mirtazapine+ Venlafaxine outperformed tranylcypromine (1) • Not statistically significant ...
BNN - Bipolar Network News
... weeks, whereas three of the four patients in the valproate only group did relapse. The naltrexone plus valproate group also had better outcome on depression, mania, alcohol craving, sleep difficulties, functioning, and reported medication side effects. • Although the study size was small, it shows t ...
... weeks, whereas three of the four patients in the valproate only group did relapse. The naltrexone plus valproate group also had better outcome on depression, mania, alcohol craving, sleep difficulties, functioning, and reported medication side effects. • Although the study size was small, it shows t ...
American Geriatrics Society 2015 Updated Beers Criteria for
... be improving the care of older adults by reducing their exposure to PIMs. This is accomplished by using the criteria as an educational tool and quality measure—two uses that are not always in agreement. These criteria are not meant to be applied in a punitive manner. Prescribing decisions are not al ...
... be improving the care of older adults by reducing their exposure to PIMs. This is accomplished by using the criteria as an educational tool and quality measure—two uses that are not always in agreement. These criteria are not meant to be applied in a punitive manner. Prescribing decisions are not al ...
Document
... – Atropine suppresses thermoregulatory sweating. – In adults, body temperature is elevated by this effect only if large doses are administered, but in infants and children even ordinary doses may cause "atropine fever." ...
... – Atropine suppresses thermoregulatory sweating. – In adults, body temperature is elevated by this effect only if large doses are administered, but in infants and children even ordinary doses may cause "atropine fever." ...
2015 insulin
... and diarrhea; voglibose (伏格列波糖), in contrast to acarbose, has less of GI side effects and more economical. ...
... and diarrhea; voglibose (伏格列波糖), in contrast to acarbose, has less of GI side effects and more economical. ...
Treatment Emergent Violence to Self and Others
... and mania have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and non-psychiatric." Although FDA has not concluded that these symptoms are a precursor to either worsening of depression ...
... and mania have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and non-psychiatric." Although FDA has not concluded that these symptoms are a precursor to either worsening of depression ...
Treatment Emergent Violence to Self and Others
... and mania have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and non-psychiatric." Although FDA has not concluded that these symptoms are a precursor to either worsening of depression ...
... and mania have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and non-psychiatric." Although FDA has not concluded that these symptoms are a precursor to either worsening of depression ...
Drugs for Parkinsonism
... • Levodopa can ameliorate all of the clinical features of parkinsonism, particularly the bradykinesia and the disabilities resulting from it. • On administration, one third of patients respond well, and one third less well. The remainder are either not able to tolerate the medication or do not respo ...
... • Levodopa can ameliorate all of the clinical features of parkinsonism, particularly the bradykinesia and the disabilities resulting from it. • On administration, one third of patients respond well, and one third less well. The remainder are either not able to tolerate the medication or do not respo ...
抗糖尿病药-胰岛素与口服降血糖药 (Antidiabetis Drugs-Insulin and
... compound. Its duration of action is about 18 hours. ...
... compound. Its duration of action is about 18 hours. ...
cAlnOfficial Journalofthe c.AmericanHeart cjlssociation
... of digitalis-induced arrhythmias.20 The mechanism responsible for this antiarrhythmic effect appears to be decreased sympathetic activity. In summary, the results of studies with orally effective dopamine agonists have suggested new approaches to the management of patients with cardiovascular diseas ...
... of digitalis-induced arrhythmias.20 The mechanism responsible for this antiarrhythmic effect appears to be decreased sympathetic activity. In summary, the results of studies with orally effective dopamine agonists have suggested new approaches to the management of patients with cardiovascular diseas ...
Research Paper Synthesis and Evaluation of Clozapine
... Schizophrenia and related psychosis, with abnormally high dopamine action apparently leading to these conditions. Numbers of drugs having the activity for blocking the neurotransmission of dopaminergic receptor in the central nervous system (Ross JB et al., 1996) have been developed. These include p ...
... Schizophrenia and related psychosis, with abnormally high dopamine action apparently leading to these conditions. Numbers of drugs having the activity for blocking the neurotransmission of dopaminergic receptor in the central nervous system (Ross JB et al., 1996) have been developed. These include p ...
The cardiotoxicity of macrolides: the role of interactions
... Several reports on in vitro and in vivo studies demonstrated the proarrhythmic potential of erythromycin. Erythromycin was shown to prolong the QT interval and action potential duration in isolated heart preparations from guinea pigs and dogs and in isolated rabbit hearts [11]. In the clinical setti ...
... Several reports on in vitro and in vivo studies demonstrated the proarrhythmic potential of erythromycin. Erythromycin was shown to prolong the QT interval and action potential duration in isolated heart preparations from guinea pigs and dogs and in isolated rabbit hearts [11]. In the clinical setti ...
Maintenance therapy with zuclopenthixol decanoate: associations
... (Bertilsson and Dahl 1996). Several studies have explored the possible association between the incidence and severity of neurological side effects induced by conventional antipsychotics and impaired metabolic capacity of CYP2D6 (Arthur et al. 1995). They found a relationship between the metabolic ca ...
... (Bertilsson and Dahl 1996). Several studies have explored the possible association between the incidence and severity of neurological side effects induced by conventional antipsychotics and impaired metabolic capacity of CYP2D6 (Arthur et al. 1995). They found a relationship between the metabolic ca ...
Atypical antipsychotic
The atypical antipsychotics (AAP; also known as second generation antipsychotics (SGAs)) are a group of antipsychotic drugs (antipsychotic drugs in general are also known as major tranquilisers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) used to treat psychiatric conditions. Some atypical antipsychotics have received regulatory approval (e.g. by the FDA of the US, the TGA of Australia, the MHRA of the UK) for schizophrenia, bipolar disorder, autism, and as an adjunct in major depressive disorder.Both generations of medication tend to block receptors in the brain's dopamine pathways. Atypicals are less likely – than the most widely-used typical antipsychotic haloperidol – to cause extrapyramidal motor control disabilities in patients such as unsteady Parkinson's disease-type movements, body rigidity, and involuntary tremors. However, only a few of the atypicals have been demonstrated to be superior to lesser-used, low-potency first-generation antipsychotics in this regard.As experience with these agents has grown, several studies have questioned the utility of broadly characterizing antipsychotic drugs as “atypical/second generation"" as opposed to “first generation,” noting that each agent has its own efficacy and side-effect profile. It has been argued that a more nuanced view in which the needs of individual patients are matched to the properties of individual drugs is more appropriate. Although atypical antipsychotics are thought to be safer than typical antipsychotics, they still have severe side effects, including tardive dyskinesia (a serious movement disorder), neuroleptic malignant syndrome, and increased risk of stroke, sudden cardiac death, blood clots, and diabetes. Significant weight gain may also occur. Critics have argued that ""the time has come to abandon the terms first-generation and second-generation antipsychotics, as they do not merit this distinction.""